Evoke Pharma (STU:EV00) Total Stockholders Equity : €3.22 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Evoke Pharma Total Stockholders Equity?

Evoke Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €3.22 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Evoke Pharma's Book Value per Share for the quarter that ended in Mar. 2024 was €0.35. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Evoke Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 was 1.43.

Evoke Pharma Total Stockholders Equity Historical Data

The historical data trend for Evoke Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoke Pharma Total Stockholders Equity Chart

Evoke Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

3.94

-2.64

3.15

3.86

-2.37

Evoke Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															1.99	0.50	-0.82	-2.37	3.22

Evoke Pharma (STU:EV00) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Evoke Pharma's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3.217	-	0)	/	9.082
	=	0.35

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Evoke Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.6	+	0)	/	3.217
	=	1.43

Evoke Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Evoke Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoke Pharma (STU:EV00) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evoke Pharma Inc (STU:EV00) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

EVOK:USA

Address

420 Stevens Avenue, Suite 370, Solana Beach, CA, USA, 92075

Website

https://www.evokepharma.com

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Evoke Pharma (STU:EV00) Headlines

No Headlines